Horizontal transfer of mitochondria

Last updated

Horizontal transfer of mitochondria is the movement of whole mitochondria and mitochondrial DNA between cells. Mitochondria from donor cells are transported and incorporated into the endogenous mitochondrial network of recipient cells contributing to changes in the bioenergetics profile and in other functional properties of recipient cells. [1] Horizontal cell-to-cell transfer of mitochondria and mitochondrial genome can occur among mammalian cells in vitro and in vivo. [2] Mitochondrial transfer supports the exogenous replacement of damaged mitochondria, thereby rescuing mitochondrial defects. [3] [4] Stem cells, immortalized cells or primary cells are usually used as mitochondrial donors in most studies. [2] These cells may transfer mitochondria to surrounding cells in their niche, thus affecting cell differentiation, proliferation, tissue homeostasis, development and ageing. [1]

Contents

Mechanism

Horizontal transfer of mitochondria is mediated by actin-rich membrane protrusions named tunneling nanotubes (TNTs). [5] The establishment of a nanotube begins with the formation of a filopodium-like membrane protrusion that retracts after reaching the recipient cell, leaving an ultrafine structure that is separated from the substrate. [1] Chemical inhibitors or mechanical stress impairs the formation of TNTs and reduces mitochondrial exchange. [1] [6] On the other hand, certain types of stress agents such as doxorubicin [7] or ethidium bromide [8] increase TNT formation. Other proposed mechanisms of transfer include membrane microvesicles, cell fusion, dendrites, and mitochondrial extrusion. [1] [9]

In vitro transfer

The first evidence of functional mitochondrial transfer in vitro has been documented between human mesenchymal stem cells (hMSCs) and human lung carcinoma cells. Healthy mitochondria from hMSCs moved to recipient lung carcinoma cells with nonfunctional mitochondria and repaired their function. [10] Intercellular transfer of mitochondria in culture has been documented from MSCs and endothelial cells to breast cancer cell lines, ovarian cancer cell lines or to osteosarcoma cell line. [11] Mitochondrial transfer can occur also between cancer cells such as mesothelioma [12] and laryngeal carcinoma cells. [13] Non-tumor cells such as human renal epithelial cells, human retinal pigment epithelial cells or human monocyte-derived macrophages have been shown to transfer their mitochondria as well. [14] All these data suggest that this phenomenon, regardless of the exact mechanisms involved, may be a fundamental physiological process well worthwhile exploring in a whole organism setting.

In vivo transfer

One of the first evidences of in vivo horizontal mitochondrial gene transfer was found in a transmissible canine venereal tumor (CTVT), highly adapted cancer transmitted during mating of feral dogs. Phylogenetic analyses of mitochondrial sequences revealed that CTVT cells periodically acquire mitochondria from its host and ensure overcoming high mutation rate that would promote the accumulation of deleterious mutations in their own mitochondria and long-term survival. [15] Transfer of intact mitochondria can contribute to tissue repair in vivo. Bone marrow-derived stem cells (BMSCs) injected into mice with acute lung injury transfer their mitochondria to lung alveoli cells and protect them against injury. [16] Overexpression of Miro1, a protein connecting mitochondria to cytoskeletal motor proteins, leads to enhanced transfer of mitochondria from MSCs into stressed epithelial cells via TNTs in mice. [17] In vivo horizontal transfer of mitochondria can occur in cancer cells which upon mitochondrial damage acquire mtDNA from surrounding donor healthy cells. This process restores transcription and translation of mtDNA-encoded genes as well as respiration. [18]

Injured neurons cannot be quickly replaced after ischemia without transfer of mitochondria from other cells. [19] Transfer of functional mitochondria from astrocytes to ischemically-damaged neurons has been shown to promote recovery in the brain. [9] [19] Stem cells are also a source of mitochondria for ischemic brain cells. [19]

Cancer

Mitochondrial transfer occurs between tumor cells and other cells of the cancer microenvironment. Highly glycolytic cancer-associated fibroblasts donate their disposable mitochondria to adjacent prostate cancer cells enhancing the respiratory capacity of the cancer cells. [9] Mitochondrial transfer in cancer cells contributes to chemotherapy resistance. [9]

Related Research Articles

<span class="mw-page-title-main">Mitochondrion</span> Organelle in eukaryotic cells responsible for respiration

A mitochondrion is an organelle found in the cells of most eukaryotes, such as animals, plants and fungi. Mitochondria have a double membrane structure and use aerobic respiration to generate adenosine triphosphate (ATP), which is used throughout the cell as a source of chemical energy. They were discovered by Albert von Kölliker in 1857 in the voluntary muscles of insects. The term mitochondrion was coined by Carl Benda in 1898. The mitochondrion is popularly nicknamed the "powerhouse of the cell", a phrase coined by Philip Siekevitz in a 1957 article of the same name.

<span class="mw-page-title-main">Mitochondrial DNA</span> DNA located in mitochondria

Mitochondrial DNA is the DNA located in mitochondria, cellular organelles within eukaryotic cells that convert chemical energy from food into a form that cells can use, such as adenosine triphosphate (ATP). Mitochondrial DNA is only a small portion of the DNA in a eukaryotic cell; most of the DNA can be found in the cell nucleus and, in plants and algae, also in plastids such as chloroplasts.

<span class="mw-page-title-main">Metastasis</span> Spread of a disease inside a body

Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; the term is typically used when referring to metastasis by a cancerous tumor. The newly pathological sites, then, are metastases (mets). It is generally distinguished from cancer invasion, which is the direct extension and penetration by cancer cells into neighboring tissues.

<span class="mw-page-title-main">Mitochondrial disease</span> Spontaneously occurring or inherited disorder that involves mitochondrial dysfunction

Mitochondrial disease is a group of disorders caused by mitochondrial dysfunction. Mitochondria are the organelles that generate energy for the cell and are found in every cell of the human body except red blood cells. They convert the energy of food molecules into the ATP that powers most cell functions.

<span class="mw-page-title-main">Carcinoma</span> Malignancy that develops from epithelial cells

Carcinoma is a malignancy that develops from epithelial cells. Specifically, a carcinoma is a cancer that begins in a tissue that lines the inner or outer surfaces of the body, and that arises from cells originating in the endodermal, mesodermal or ectodermal germ layer during embryogenesis.

<span class="mw-page-title-main">Homoplasmy</span> Identity of organellar DNA sequences in a cell

Homoplasmy is a term used in genetics to describe a eukaryotic cell whose copies of mitochondrial DNA are all identical. In normal and healthy tissues, all cells are homoplasmic. Homoplasmic mitochondrial DNA copies may be normal or mutated; however, most mutations are heteroplasmic. It has been discovered, though, that homoplasmic mitochondrial DNA mutations may be found in human tumors.

<span class="mw-page-title-main">Human mitochondrial genetics</span> Study of the human mitochondrial genome

Human mitochondrial genetics is the study of the genetics of human mitochondrial DNA. The human mitochondrial genome is the entirety of hereditary information contained in human mitochondria. Mitochondria are small structures in cells that generate energy for the cell to use, and are hence referred to as the "powerhouses" of the cell.

<span class="mw-page-title-main">T-box transcription factor T</span> Protein-coding gene in the species Homo sapiens

T-box transcription factor T, also known as Brachyury protein, is encoded for in humans by the TBXT gene. Brachyury functions as a transcription factor within the T-box family of genes. Brachyury homologs have been found in all bilaterian animals that have been screened, as well as the freshwater cnidarian Hydra.

<span class="mw-page-title-main">Oncogenomics</span> Sub-field of genomics

Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer.

Nuclear mitochondrial DNA (NUMT) segments or genetic loci describe a transposition of any type of cytoplasmic mitochondrial DNA into the nuclear genome of eukaryotic organisms.

<span class="mw-page-title-main">KLF4</span> Protein-coding gene in the species Homo sapiens

Kruppel-like factor 4 is a member of the KLF family of zinc finger transcription factors, which belongs to the relatively large family of SP1-like transcription factors. KLF4 is involved in the regulation of proliferation, differentiation, apoptosis and somatic cell reprogramming. Evidence also suggests that KLF4 is a tumor suppressor in certain cancers, including colorectal cancer. It has three C2H2-zinc fingers at its carboxyl terminus that are closely related to another KLF, KLF2. It has two nuclear localization sequences that signals it to localize to the nucleus. In embryonic stem cells (ESCs), KLF4 has been demonstrated to be a good indicator of stem-like capacity. It is suggested that the same is true in mesenchymal stem cells (MSCs).

<span class="mw-page-title-main">DNAJA3</span> Protein-coding gene in the species Homo sapiens

DnaJ homolog subfamily A member 3, mitochondrial, also known as Tumorous imaginal disc 1 (TID1), is a protein that in humans is encoded by the DNAJA3 gene on chromosome 16. This protein belongs to the DNAJ/Hsp40 protein family, which is known for binding and activating Hsp70 chaperone proteins to perform protein folding, degradation, and complex assembly. As a mitochondrial protein, it is involved in maintaining membrane potential and mitochondrial DNA (mtDNA) integrity, as well as cellular processes such as cell movement, growth, and death. Furthermore, it is associated with a broad range of diseases, including neurodegenerative diseases, inflammatory diseases, and cancers.

<span class="mw-page-title-main">Cytochrome c oxidase subunit I</span> Enzyme of the respiratory chain encoded by the mitochondrial genome

Cytochrome c oxidase I (COX1) also known as mitochondrially encoded cytochrome c oxidase I (MT-CO1) is a protein that is encoded by the MT-CO1 gene in eukaryotes. The gene is also called COX1, CO1, or COI. Cytochrome c oxidase I is the main subunit of the cytochrome c oxidase complex. In humans, mutations in MT-CO1 have been associated with Leber's hereditary optic neuropathy (LHON), acquired idiopathic sideroblastic anemia, Complex IV deficiency, colorectal cancer, sensorineural deafness, and recurrent myoglobinuria.

<span class="mw-page-title-main">FOXM1</span> Protein-coding gene in humans

Forkhead box protein M1 is a protein that in humans is encoded by the FOXM1 gene. The protein encoded by this gene is a member of the FOX family of transcription factors. Its potential as a target for future cancer treatments led to it being designated the 2010 Molecule of the Year.

<span class="mw-page-title-main">FATE1</span> Protein-coding gene in the species Homo sapiens

Fetal and Adult Testis-Expressed 1, encoded by the FATE1 gene in humans, is a protein identified as a cancer-testis antigen (CTA) in hepatocellular carcinomas and gastric and colon cancers. It is testis-specific in the fetus. In adults, it is expressed predominantly in the testis and adrenal glands, with some expression in the lungs, heart, kidneys and throughout the brain.

<span class="mw-page-title-main">Tunneling nanotube</span> Biological structure

A tunneling nanotube(TNT) or membrane nanotube is a term that has been applied to cytoskeletal protrusions that extend from the plasma membrane which enable different animal cells to connect over long distances, sometimes over 100 μm between certain types of cells. Tunneling nanotubes that are less than 0.7 micrometers in diameter, have an actin structure and carry portions of plasma membrane between cells in both directions. Larger TNTs (>0.7 μm) contain an actin structure with microtubules and/or intermediate filaments, and can carry components such as vesicles and organelles between cells, including whole mitochondria. The diameter of TNTs ranges from 0.05 μm to 1.5 μm and they can reach lengths of several cell diameters. There have been two types of observed TNTs: open ended and closed ended. Open ended TNTs connect the cytoplasm of two cells. Closed ended TNTs do not have continuous cytoplasm as there is a gap junction cap that only allows small molecules and ions to flow between cells. These structures have shown involvement in cell-to-cell communication, transfer of nucleic acids such as mRNA and miRNA between cells in culture or in a tissue, and the spread of pathogens or toxins such as HIV and prions. TNTs have observed lifetimes ranging from a few minutes up to several hours, and several proteins have been implicated in their formation and inhibition, including many that interact with Arp2/3.

Michael Vivian Berridge is a New Zealand cell biologist. Since 1976, he has led the cancer cell and molecular biology research group at the Malaghan Institute of Medical Research. He is also a professor at Victoria University of Wellington and a Distinguished Research Fellow at the Malaghan Institute of Medical Research. He is best known for elucidating cellular mechanisms of reduction of tetrazolium dyes that are widely used in biology, and for the discovery of mitochondrial genome transfer from healthy cells to mitochondrial DNA-deficient cancer cells.

Mitophagy is the selective degradation of mitochondria by autophagy. It often occurs to defective mitochondria following damage or stress. The process of mitophagy was first described over a hundred years ago by Margaret Reed Lewis and Warren Harmon Lewis. Ashford and Porter used electron microscopy to observe mitochondrial fragments in liver lysosomes by 1962, and a 1977 report suggested that "mitochondria develop functional alterations which would activate autophagy." The term "mitophagy" was in use by 1998.

mir-200

In molecular biology, the miR-200 microRNA is a short RNA molecule. MicroRNAs function to regulate the expression levels of other genes by binding and cleaving mRNAs or inhibiting translation. The miR-200 family contains miR-200a, miR-200b, miR-200c, miR-141, and miR-429. There is growing evidence to suggest that miR-200 microRNAs are involved in cancer metastasis.

<span class="mw-page-title-main">Mesenchymal stem cell</span> Multipotent, non-hematopoietic adult stem cells present in multiple tissues

Mesenchymal stem cells (MSCs) also known as mesenchymal stromal cells or medicinal signaling cells, are multipotent stromal cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes and adipocytes.

References

  1. 1 2 3 4 5 Torralba, D.; Baixauli, F.; Sánchez-Madrid, F. (2016). "Mitochondria know no boundaries: Mechanisms and functions of intercellular mitochondrial transfer". Frontiers in Cell and Developmental Biology. 4. 107. doi: 10.3389/fcell.2016.00107 . PMC   5039171 . PMID   27734015.
  2. 1 2 Berridge, M.V; McConnell, M.J; Grasso, C.; Bajzikova, M.; Kovarova, J.; Neuzil, J. (2016). "Horizontal transfer of mitochondria between mammalian cells: beyond co-culture approaches". Current Opinion in Genetics & Development. 38: 75–82. doi:10.1016/j.gde.2016.04.003. PMID   27219870.
  3. ↑ Patananan, A.N; Wu, T.H.; Chiou, P.Y.; Teitell, M. A. (2016). "Modifying the Mitochondrial Genome". Cell Metabolism. 23 (5): 785–796. doi:10.1016/j.cmet.2016.04.004. PMC   4864607 . PMID   27166943.
  4. ↑ Hayakawa, K.; Esposito, E.; Wang, X.; Terasaki, Y.; Liu, Y.; Xing, Ch.; Ji, X.; Lo, E.H. (2016). "Transfer of mitochondria from astrocytes to neurons after stroke". Nature. 535 (7613): 551–555. Bibcode:2016Natur.535..551H. doi:10.1038/nature18928. PMC   4968589 . PMID   27466127.
  5. ↑ Rustom, A.; Saffrich, R.; Markovic, I.; Walther, P.; Gerdes, H.H (2004). "Nanotubular highways for intercellular organelle transport". Science. 303 (5660): 1007–1010. Bibcode:2004Sci...303.1007R. doi:10.1126/science.1093133. PMID   14963329.
  6. ↑ Bukoreshtliev, N.V.; Wang, X.; Hodneland, E.; Gurke, S.; Barroso, J.F.V.; Gerdes, H.H (2009). "Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells". FEBS Letters. 583 (9): 1481–1488. doi:10.1016/j.febslet.2009.03.065. PMID   19345217.
  7. ↑ Yasuda, K.; Park, H.Ch.; Ratliff, B.; Addabbo, F.; Hatzopoulos, A.K.; Chander, P.; Goligorsky, M.S. (2010). "Adriamycin Nephropathy". The American Journal of Pathology. 176 (4): 1685–1695. doi:10.2353/ajpath.2010.091071. PMC   2843460 . PMID   20167859.
  8. ↑ Cho, Y.M.; Kim, J.H.; Kim, M.; Park, S.J.; Koh, S.H.; Ahn, H.S.; Kang, G.H.; Lee, J.B; Park, K.S.; Lee, H.K.; Moran, M. (2012). "Mesenchymal Stem Cells Transfer Mitochondria to the Cells with Virtually No Mitochondrial Function but Not with Pathogenic mtDNA Mutations". PLOS ONE. 7 (3): e32778. Bibcode:2012PLoSO...732778C. doi: 10.1371/journal.pone.0032778 . PMC   3295770 . PMID   22412925.
  9. 1 2 3 4 Liu D, Gao Y, Gao J (2021). "Intercellular mitochondrial transfer as a means of tissue revitalization". Signal Transduction and Targeted Therapy . 6 (1): 65. doi:10.1038/s41392-020-00440-z. PMC   7884415 . PMID   33589598.
  10. ↑ Spees, J.L; Olson, S.D; Whitney, M.J; Prockop, D.J (2006). "Mitochondrial transfer between cells can rescue aerobic respiration". Proc Natl Acad Sci USA. 103 (5): 1283–1288. Bibcode:2006PNAS..103.1283S. doi: 10.1073/pnas.0510511103 . PMC   1345715 . PMID   16432190.
  11. ↑ Neuzil, J.; Dong, L.; Berridge, M.V. (2015). "Mitochondrial DNA in Tumor Initiation, Progression, and Metastasis: Role of Horizontal mtDNA Transfer". Cancer Research. 75 (16): 3203–3208. doi: 10.1158/0008-5472.CAN-15-0859 . ISSN   0008-5472.
  12. ↑ Lou, E.; Fujisawa, S.; Morozov, A.; Barlas, A.; Romin, Y.; Dogan, Y.; Gholami, S.; Moreira, A.L.; Manova-Todorova, K.; Moore, M. A. S.; Yang, P.CH (2012). "Tunneling Nanotubes Provide a Unique Conduit for Intercellular Transfer of Cellular Contents in Human Malignant Pleural Mesothelioma". PLOS ONE. 7 (3): e33093. Bibcode:2012PLoSO...733093L. doi: 10.1371/journal.pone.0033093 . PMC   3302868 . PMID   22427958.
  13. ↑ Antanavičiūtė, I.; Rysevaitė, K.; Liutkevičius, V.; Marandykina, A.; Rimkutė, L.; Sveikatienė, R.; Uloza, V.; Skeberdis, V.; Scemes, E. (2014). "Long-Distance Communication between Laryngeal Carcinoma Cells". PLOS ONE. 9 (6): e99196. Bibcode:2014PLoSO...999196A. doi: 10.1371/journal.pone.0099196 . PMC   4063716 . PMID   24945745.
  14. ↑ Caicedo, A.; Aponte, P.M.; Cabrera, F.; Hidalgo, C.; Khoury, M. (2017). "Artificial Mitochondria Transfer: Current Challenges, Advances, and Future Applications". Stem Cells International. 2017: 1–23. doi: 10.1155/2017/7610414 . PMC   5511681 . PMID   28751917.
  15. ↑ Rebbeck, C.A; Leroi, A.M; Burt, A. (2011). "Mitochondrial capture by a transmissible cancer". Science. 331 (6015): 303. Bibcode:2011Sci...331..303R. doi:10.1126/science.1197696. PMID   21252340.
  16. ↑ Islam, M.N; Das, S.R; Emin, M.T; Wei, M.; Sun, L.; Westphalen, K.; Rowlands, D.J; Quadri, S.K; Bhattacharya, S.; Bhattacharya, J. (2012). "Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury". Nature Medicine. 18 (5): 759–765. doi:10.1038/nm.2736. PMC   3727429 . PMID   22504485.
  17. ↑ Ahmad, T.; Mukherjee, S.; Pattnaik, B.; Kumar, M.; Singh, S.; Kumar, M.; et al. (2014). "Miro1 regulates intercellular mitochondrial transport and enhances mesenchymal stem cell rescue efficacy". EMBO J. 33 (9): 994–1010. doi:10.1002/embj.201386030. PMC   4193933 . PMID   24431222.
  18. ↑ Tan, A.S; Baty, J.W; Dong, L.F; Bezawork-Geleta, A.; Endaya, B.; Goodwin, J.; Bajzikova, M.; Kovarova, J.; Peterka, M.; Yan, B.; Pesdar, E.A; Sobol, M.; Filimonenko, A.; Stuart, S.; Vondrusova, M.; Kluckova, K.; Sachaphibulkij, K.; Rohlena, J.; Hozak, P.; Truksa, J.; Eccles, D.; Haupt, L.M; Griffiths, L.R; Neuzil, J.; Berridge, M.V (2015). "Mitochondrial genome acquisition restores respiratory function and tumorigenic potential of cancer cells without mitochondrial DNA". Cell Metabolism. 21 (1): 81–91. doi: 10.1016/j.cmet.2014.12.003 . PMID   25565207.
  19. 1 2 3 An H, Zhou B, Ji X (2021). "Mitochondrial quality control in acute ischemic stroke". Journal of Cerebral Blood Flow & Metabolism . 41 (12): 3157–3170. doi:10.1177/0271678X211046992. PMC   8669286 . PMID   34551609.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.